Clinical Trials Directory

Trials / Terminated

TerminatedNCT01142921

The Patency Period of the New Plastic Anti-reflux Biliary Stent

A Prospective Randomised Study on the Patency Period of the Plastic Anti-reflux Biliary Stent

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the average patency period of the new anti-reflux biliary stent on patients with malignant bile duct strictures and to determine if this stent remains patent for a longer period of time comparing with the ordinary plastic Tannenbaum biliary stent.

Detailed description

Bile duct related cancer is a condition quite commonly seen among Asians. Predisposing conditions for primary bile duct cancer include recurrent infections and autoimmune diseases such as recurrent pyogenic cholangitis (RPC) and primary sclerosing cholangitis (PSC) as well as congenital problem such as choledochal cyst. Peri-ampullary tumour, pancreatic tumour and metastatic tumours with bile duct compression are other causes of bile duct obstruction. As many of these tumours are discovered at a late stage, curative treatment is usually not feasible. Palliative endoscopic stenting of the obstructed biliary system remains the treatment of choice for the majority. The main problem with endoscopic stenting of the biliary system is the short stent patency period. There are some reports on modifications to plastic biliary stenting method in recent years including changes in stent designs, use of a different material or coating, administrating prophylactic antibiotics and the use of special drugs. All these have failed to show any conclusive effect on the stent patency period. A preliminary study has demonstrated some promising results in the use of a stent with an anti-reflux property very similar to the stents the investigators are using in this study.

Conditions

Interventions

TypeNameDescription
DEVICEAnti-reflux Tannenbaum biliary stentAnti-reflux Tannenbaum biliary stent
DEVICEOrdinary Tannenbaum biliary stentOrdinary Tannenbaum biliary stent

Timeline

Start date
2008-11-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2010-06-14
Last updated
2017-04-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01142921. Inclusion in this directory is not an endorsement.